Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-01-05 | Athira Pharma, Inc. | Litton Mark James
(CEO) |
S | Common Stock | D | 4820 | $2.91 - $2.91 | $14,026 |
| 2024-01-04 | Athira Pharma, Inc. | Litton Mark James
(CEO) |
A | Common Stock | A | 20000 | $0.00 - $0.00 | $0 |
| 2024-01-05 | Athira Pharma, Inc. | Worthington Mark
(GENERAL COUNSEL) |
S | Common Stock | D | 2412 | $2.91 - $2.91 | $7,018 |
| 2023-05-18 | Athira Pharma, Inc. | Worthington Mark
(GENERAL COUNSEL) |
A | Common Stock | A | 17767 | $2.41 - $2.41 | $18,718 |
| 2024-01-04 | Athira Pharma, Inc. | MOEBIUS HANS
(Chief Medical Officer) |
A | Common Stock | A | 10000 | $0.00 - $0.00 | $0 |
| 2024-01-05 | Athira Pharma, Inc. | Worthington Mark
(General Counsel) |
S | Common Stock | D | 2412 | $2.91 - $2.91 | $7,018 |
| 2023-05-18 | Athira Pharma, Inc. | Worthington Mark
(General Counsel) |
A | Common Stock | A | 17767 | $2.41 - $2.41 | $18,718 |
| 2023-01-05 | Athira Pharma, Inc. | CHURCH KEVIN
(Chief Scientific Officer) |
S | Common Stock | D | 2412 | $2.91 - $2.91 | $7,018 |
| 2023-05-18 | Athira Pharma, Inc. | CHURCH KEVIN
(Chief Scientific Officer) |
A | Common Stock | A | 14206 | $1.34 - $2.41 | $6,500 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |